Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative splicing and disease.

Eddo Kim1, Amir Goren, Gil Ast

  • 1Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Israel. kimedd@post.tau.ac.il

RNA Biology
|April 5, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histone H1 variants regulate neurodevelopmental transcriptional programs in autism with 16p11.2 deletion.

Genome biology·2026
Same author

Timely nudges promote patient portal enrollment and sustained engagement: a randomized controlled trial.

JAMIA open·2026
Same author

A network-based method for associating genes with autism spectrum disorder.

Frontiers in bioinformatics·2024
Same author

Comparison of Clinical Decision Support Tools to Improve Pediatric Lipid Screening.

The Journal of pediatrics·2024
Same author

Human histone H1 variants impact splicing outcome by controlling RNA polymerase II elongation.

Molecular cell·2023
Same author

Ataxia Telangiectasia Mutated Signaling Delays Skin Pigmentation upon UV Exposure by Mediating MITF Function toward DNA Repair Mode.

The Journal of investigative dermatology·2023
Same journal

RNA polymerase II phosphorylation dynamics: from molecular mechanisms to human disease.

RNA biology·2026
Same journal

Impact of interspecies colostrum and milk replacement on circulating sncRNA dynamics of neonatal goat kids.

RNA biology·2026
Same journal

The role of RNA modifications in cancer translational control.

RNA biology·2026
Same journal

Discovery of a mutation-containing circRNA in polyglutamine disease through systematic analysis of RNAs with CAG repeats.

RNA biology·2026
Same journal

FDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook.

RNA biology·2026
Same journal

The RNA binding protein ZFP36L2 displays tissue-selective mRNA targeting in mice.

RNA biology·2026
See all related articles

Mutations affecting mRNA splicing can cause severe diseases and potentially mild phenotypic differences. These splicing defects are also implicated in cancer, altering gene expression and exon skipping.

Area of Science:

  • Molecular Biology
  • Genetics
  • Human Health

Background:

  • Splicing is a crucial post-transcriptional modification process where introns are removed from pre-mRNA and exons are joined to form mature mRNA.
  • Mutations in splicing are linked to severe genetic disorders like cystic fibrosis and familial dysautonomia.
  • Splicing alterations are also observed in various cancers, affecting gene expression and alternative splicing patterns.

Purpose of the Study:

  • To explore the role of splicing mutations in causing both severe and mild deleterious phenotypic differences.
  • To investigate the impact of splicing defects on cancer development and progression.
  • To re-evaluate the role of splicing silencers in alternative splicing regulation.

Main Methods:

  • Review of existing literature on splicing mechanisms and mutations.

Related Experiment Videos

  • Analysis of gene expression data in cancerous tissues related to mRNA processing.
  • Examination of exon skipping levels in human cancers.

    • Main Results:

    • Mutations in splicing can lead to a spectrum of phenotypic effects, from severe to mild.
    • Cancerous tissues exhibit altered expression of splicing-related genes and reduced exon skipping.
    • Splicing defects in cancer may shift alternative splicing towards constitutive splicing.

    Conclusions:

    • Mildly deleterious splicing mutations may be misclassified as neutral variation due to weaker purifying selection.
    • Splicing dysregulation is a significant factor in cancer pathology.
    • Splicing silencers might play a more critical role in alternative splicing regulation than previously understood.